What biomarker tests are recommended for Head and Neck Cancer

Biomarker Testing for Head and Neck Cancer

I'd be happy to explain the key biomarker tests that are important for head and neck cancer patients. These tests help your oncology team understand your cancer's characteristics and guide treatment decisions.

Primary Biomarkers for Head and Neck Cancer

HPV (Human Papillomavirus) Status

This is one of the most important biomarkers. HPV-positive head and neck cancers (particularly oropharyngeal cancers) have different characteristics and often respond better to treatment than HPV-negative cancers. Your pathology report should clearly state whether your tumor is HPV-positive or HPV-negative.

p16 Expression

Often tested alongside HPV status, p16 is a protein that's typically elevated in HPV-positive tumors. This helps confirm HPV status and has prognostic significance.

Tumor Grade and Differentiation

Your pathology report describes how abnormal the cancer cells appear under the microscope—this affects treatment planning and prognosis.

Margin Status

Whether cancer cells are present at the edges of the surgical specimen (if surgery was performed) is critical for determining if additional treatment is needed.

Additional Biomarkers Being Studied

Researchers are investigating other biomarkers like:

• PD-L1 expression (relates to immunotherapy response)
• Microsatellite instability (MSI)
• Tumor mutational burden (TMB)

These are increasingly relevant as immunotherapy options expand for head and neck cancer.

What You Should Know

According to NCCN (National Comprehensive Cancer Network) Guidelines for Head and Neck Cancers, HPV/p16 testing is recommended for all patients with oropharyngeal squamous cell carcinoma, as it significantly impacts treatment recommendations and prognosis.

Questions to Ask Your Oncology Team

1. Has my tumor been tested for HPV status? If not, why not?
2. What was my p16 expression result, and what does it mean for my treatment?
3. Are there any other biomarkers my team recommends testing given my specific cancer type and location?
4. How do my biomarker results influence which treatment approach you're recommending?
5. Are there any clinical trials available that target specific biomarkers in my tumor?

Important Note

The specific biomarkers recommended can vary based on:

• Your cancer's location (larynx, pharynx, oral cavity, etc.)
• Whether you had surgery or are being treated with radiation/chemotherapy
• Your overall health and treatment goals

Your oncologist will determine which tests are most relevant for YOUR specific situation based on your complete clinical picture.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.